期刊文献+

沙美特罗替卡松粉吸入剂中沙美特罗和丙酸氟替卡松的HPLC测定 被引量:2

Determination of Salmeterol and Fluticasone Propionate in Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation by HPLC
下载PDF
导出
摘要 建立了HPLC法测定沙美特罗替卡松粉吸入剂中的沙美特罗和丙酸氟替卡松。采用C18色谱柱,以甲醇-0.05mol/L乙酸铵溶液(68︰32)为流动相,检测波长228nm。沙美特罗和丙酸氟替卡松分别在0.14~27.4μg/ml和0.3~60μg/ml浓度范围内线性关系良好;回收率为101.3%和101.5%。 An HPLC method was established for the determination of salmeterol and fluticasone propionate in salmeterol xinafoate and fluticasone propionate powder for inhalation. A C18 column was used with the mobile phase of methanol-0.05 mol/L ammonium acetate (68 : 32)at detection wavelength of 228 nm. The calibration curves for salmeterol and fluticasone propionate were linear in the concentration ranges of 0.14-27.4μg/ml and 0.3-60 μg/ml. The recoveries were 101.3 % and 101.5 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2009年第12期931-933,共3页 Chinese Journal of Pharmaceuticals
关键词 沙美特罗替卡松粉吸入剂 沙美特罗 丙酸氟替卡松 高效液相色谱 测定 salmeterol xinafoate and fluticasone propionate powder for inhalation salmeterol fluticasone propionate HPLC determination
  • 相关文献

参考文献3

  • 1林士军,王桂杰,刘玉春,董惠翔.舒利迭治疗支气管哮喘的临床观察[J].临床肺科杂志,2009,14(2):188-189. 被引量:78
  • 2Westmeier R, Steckel H. Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment [J]. J Pharm Sci, 2008, 97 (6) : 2299-2310.
  • 3Murnane D, Martin GP, Marriott C. Validation of a reversephase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate) [J]. JPharm Biomed Anal, 2006, 40 (5): 1149-1154.

二级参考文献10

  • 1段建明,安新,张继艳.沙美特罗联合氟替卡松治疗咳嗽变异型哮喘38例临床观察[J].临床肺科杂志,2006,11(6):714-714. 被引量:29
  • 2Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immuno1,2004, 115 ( 1 ) :59 -65.
  • 3Bousquet J, Jeffery PK. Busse WW, et al. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med,2000,161 (5) :1720 -1745.
  • 4Van den Berg N J, Ossip MS, Hederos CA, et al. Salmeterol/fluticasone propionate (50/100 micog) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatric Pulmonology ,2000,30 (2) :97 - 105.
  • 5Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med, 2004,170 ( 8 ) : 836 - 844.
  • 6Dahl R, Chuchalin A, Gor D, et al. EXCEL: A randomised trial comparing salmeteroL/fluticasone propionate and formoterolfbudesonide combinations in adults with persistent asthma. Respir Med, 2006,100(7) :1152 - 1162.
  • 7GINA 2006. http://www. ginasthma, com.
  • 8Jeannin P, Lecoanet S, Delneste Y, et al. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol, 1998,160 (7) :3555 -3561.
  • 9中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3564
  • 10中华医学会呼吸病学分会哮喘学组,殷凯生,林江涛.第四届全国支气管哮喘学术会议纪要[J].中华结核和呼吸杂志,2003,26(3):175-177. 被引量:23

共引文献77

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部